SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-14-003076
Filing Date
2014-11-14
Accepted
2014-11-14 09:00:51
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q biostarpharma093014.htm 10-Q 1222838
2 EX-31.1 ex31-1.htm EX-31.1 16574
3 EX-31.2 ex31-2.htm EX-31.2 16152
4 EX-32.1 ex32-1.htm EX-32.1 7686
5 EX-32.2 ex32-2.htm EX-32.2 6872
  Complete submission text file 0001185185-14-003076.txt   7522054

Data Files

Seq Description Document Type Size
6 EX-101.INS bspm-20140930.xml EX-101.INS 1249527
7 EX-101.SCH bspm-20140930.xsd EX-101.SCH 52708
8 EX-101.CAL bspm-20140930_cal.xml EX-101.CAL 49539
9 EX-101.DEF bspm-20140930_def.xml EX-101.DEF 271326
10 EX-101.LAB bspm-20140930_lab.xml EX-101.LAB 335500
11 EX-101.PRE bspm-20140930_pre.xml EX-101.PRE 273458
Mailing Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046
Business Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046 011-86-29-33686638
Biostar Pharmaceuticals, Inc. (Filer) CIK: 0001418133 (see all company filings)

IRS No.: 000000000 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34708 | Film No.: 141220758
SIC: 2834 Pharmaceutical Preparations